Apramycin

N/A

Report date: 2022/10/24 20:00:44
NME

Base Information

Drug NameApramycin
Drug Alias NameNebramycin II (sulfa te)Nebramyci n factor 2RP-41578
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitorsProtein biosynthesis inhibitors
TargetsTubulin
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of ZurichSanofiUppsala University
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesJuvabis Ag
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG